Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2683_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Series Editors’ foreword
- •Prefaces
- •Acknowledgements
- •Series Editors’ acknowledgements
- •History of the presenting complaint (HPC)
- •Past medical history (PMH)
- •Medications and allergies (DHX)
- •Family history (FHX)
- •Social history (SHX)
- •Systems review (SR)
- •General symptoms
- •Fatigue
- •Appetite
- •Weight change
- •Sweats
- •Pruritus (itching)
- •Sleep pattern
- •Cardiovascular symptoms
- •Chest pain
- •Shortness of breath (dyspnoea) and exercise tolerance
- •Loss of consciousness (syncope)
- •Palpitations
- •Ankle and calf swelling
- •Calf, thigh or buttock pain on exertion (claudication)
- •Respiratory symptoms
- •Dyspnoea
- •Cough
- •Sputum
- •Chest pain
- •Wheeze
- •Hoarse voice
- •Gastrointestinal disease
- •Abdominal pain
- •Dysphagia
- •Nausea and vomiting
- •Indigestion
- •Change in bowel habit or stools
- •Jaundice and itch
- •Abdominal swelling
- •Genitourinary symptoms
- •Dysuria
- •Change in urine appearance
- •Frequency and nocturia
- •Hesitancy
- •Contents
- •Loin pain
- •Incontinence
- •Menstruation
- •Discharge
- •Neurological symptoms
- •Headache
- •Dizziness and vertigo
- •Loss of consciousness
- •Visual disturbance
- •Altered hearing
- •General principles
- •Altered smell
- •Speech disturbance
- •Limb weakness, paraesthesiae and sensory loss
- •Metabolic and endocrine symptoms
- •Musculoskeletal symptoms
- •Pain
- •Weakness
- •Overview
- •The history
- •Presenting complaint (PC)
- •Visual survey
- •Position
- •Hands
- •Radial pulse
- •Blood pressure
- •Brachial and carotid artery
- •Jugular Venous Pressure
- •Face
- •Praecordium
- •Apex beat
- •Palpation
- •Auscultation
- •Summary
- •The respiratory system
- •Visual survey
- •Stiffness
- •Joint swelling
- •Disability
- •Skin symptoms
- •Rash
- •Pruritus
- •Precipitants
- •Haematological symptoms
- •Fatigue
- •Excessive bleeding or bruising
- •Recurrent infections
- •Glandular swelling
- •Conclusion of history taking
- •2 Clinical examination
- •ABCDE approach
- •Massive Blood Loss Protocol
- •General principles
- •Visual survey
- •Patient position, general behaviour and around the bed
- •Pallor
- •Cyanosis
- •Jaundice
- •Fluid status
- •Pigmentation
- •The face and body habitus
- •The hands
- •Hands
- •Nails
- •Tendons
- •Joints
- •Neuromuscular
- •Miscellaneous
- •The cardiovascular system
- •Position
- •Hands
- •Pulse
- •Blood pressure
- •Jugular venous pressure
- •Face and mouth
- •Trachea
- •Thorax
- •Inspection
- •Expansion
- •Tactile fremitus and vocal fremitus
- •Percussion
- •Auscultation
- •Summary
- •The abdomen
- •Visual survey
- •Position
- •Hands
- •Arms
- •Face and mouth
- •Neck
- •Trunk and back
- •Abdomen
- •Inspection
- •Palpation
- •Percussion
- •Auscultation
- •Concluding your examination
- •The nervous system
- •Visual survey
- •Cranial nerves
- •Cranial nerve I (olfactory nerve)
- •Cranial nerve II (optic nerve)
- •Cranial nerves III, IV and VI and eye movements
- •Cranial nerve III (oculomotor nerve)
- •Cranial nerve IV (trochlear nerve)
- •Cranial nerve VI (abducens nerve)
- •Cranial nerve V (trigeminal nerve)
- •Cranial nerve VII (facial nerve)
- •Cranial nerve VIII (vestibulocochlear nerve)
- •Cranial nerve IX (glossopharyngeal nerve)
- •Cranial nerve X (vagus nerve)
- •Cranial nerve XI (accessory nerve)
- •Cranial nerve XII (hypoglossal nerve)
- •Upper limb
- •Visual survey
- •Tone
- •Power
- •Coordination
- •Reflexes
- •Sensation
- •Lower limb
- •Visual survey
- •Tone
- •Power
- •Coordination
- •Reflexes
- •Sensation
- •Gait
- •Musculoskeletal examination
- •Visual survey
- •Look
- •Feel
- •Move
- •Assessment of disability
- •Hands
- •Skin and lymphadenopathy
- •Breast examination
- •Neck examination
- •3 Writing in the medical notes
- •General principles
- •Sample clerking
- •4 Chest pain
- •Introduction
- •History and examination findings
- •History
- •Type of chest pain
- •Onset and progression
- •Site and radiation
- •Nature of pain
- •Associated symptoms
- •Examination
- •Investigations
- •5 Shortness of breath
- •Introduction
- •History and examination findings
- •History
- •Onset
- •Severity
- •Precipitating and aggravating factors
- •Associated features
- •Other factors
- •Examination
- •Inspection
- •Palpation
- •Percussion
- •Auscultation
- •Investigations
- •Acute presentation
- •Chronic presentation
- •6 Cough and haemoptysis
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Bedside
- •Blood tests
- •Imaging
- •Further investigations
- •7 Palpitations
- •Introduction
- •History and examination findings
- •History
- •Causes and contributing factors
- •Examination
- •Investigations
- •8 Pyrexia of unknown origin
- •Introduction
- •History and examination findings
- •Investigations
- •Bedside investigations
- •Blood tests
- •Microbiology tests
- •Further investigations
- •Differential diagnosis
- •9 Abdominal pain
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Ascertaining the underlying causes of abdomnal pain
- •Investigations
- •Bedside investigations
- •Blood tests
- •Imaging
- •Further investigations
- •10 Heartburn and indigestion
- •Introduction
- •History and examination findings
- •Investigations
- •Common investigations
- •Specialized investigations
- •11 Gastrointestinal bleed
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Further investigations
- •12 Change in bowel habit
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Imaging
- •Noninvasive
- •Invasive
- •Further investigations
- •13 Weight loss
- •Introduction
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Blood tests
- •Imaging
- •14 Jaundice
- •Introduction
- •History and examination
- •History
- •Examination
- •Investigations
- •Haemolysis screen
- •Hepatocellular screen
- •Introduction
- •Micturition disturbances
- •History and examination findings
- •Examination
- •General appearance
- •Cardiovascular system
- •Abdominal examination
- •Neurological examination
- •Investigations
- •Urine tests
- •Blood tests
- •Imaging
- •Further investigations
- •Haematuria
- •History and examination findings
- •Initial tests
- •Imaging
- •Other investigations
- •Proteinuria
- •16 Headache and facial pain
- •Introduction
- •History and examination findings
- •History
- •Solitary acute episode
- •Progressive headache
- •Recurrent episodic headache and facial pain
- •Chronic headache and facial pain
- •Examination
- •Investigations
- •Blood tests
- •Imaging
- •Introduction
- •History and examination findings
- •Investigations
- •Imaging
- •Further investigations
- •Differential diagnosis
- •Thyroid disease
- •Hypothyroidism
- •Aetiology
- •Clinical features
- •Investigations
- •Blood tests
- •Other
- •Imaging
- •Hyperthyroidism
- •Aetiology
- •Primary hyperthyroidism
- •Clinical features
- •Investigations
- •Subacute (de Quervain) thyroiditis
- •Thyroid malignancy
- •Papillary thyroid carcinoma
- •Follicular thyroid carcinoma
- •Anaplastic carcinoma
- •Medullary thyroid carcinoma
- •Primary thyroid lymphoma
- •Further reading
- •18 Loss of consciousness
- •Introduction
- •History and examination findings
- •History
- •Before the event
- •The event itself
- •After the event
- •Risk factors
- •Examination
- •Comatose patient
- •Patient with blackouts
- •Investigations
- •19 Confusion and delirium
- •Introduction
- •History and examination findings
- •History
- •Pattern of confusion
- •Underlying causes
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Further tests
- •20 Stroke and TIA
- •Introduction
- •Causes and pathophysiology
- •History and examination findings
- •History
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Imaging
- •Further investigations
- •Management
- •Acute treatment
- •Prevention
- •21 Lumps
- •Introduction
- •History and examination findings
- •Investigations
- •Differential diagnosis
- •Localized lymphadenopathy
- •Generalized lymphadenopathy
- •Splenomegaly
- •22 Focal neurological deficits
- •Introduction
- •History and examination findings
- •History
- •Pattern of deficit
- •Onset
- •Precipitants
- •Progression
- •Evidence of cause
- •Examination
- •The anatomical site of the lesion
- •The underlying cause
- •The resultant disability
- •Investigations
- •Bedside investigations
- •Blood tests
- •Cerebrospinal fluid analysis
- •Imaging
- •Further investigations
- •23 Dizziness and vertigo
- •Introduction
- •History and examination findings
- •History
- •Onset and pattern of vertigo
- •Aural symptoms
- •Neurological symptoms
- •Examination
- •Investigations
- •24 Back pain and joint pain
- •Introduction
- •History and examination findings
- •History
- •Ask about associated features:
- •Other important points to consider include:
- •Examination
- •Investigations
- •Bedside investigations
- •Blood tests
- •Imaging
- •Differential diagnosis
- •Joint disease
- •Back pain
- •25 Skin lesions and rash
- •Introduction
- •History and examination
- •History
- •Examination
- •Investigations
- •Differential diagnosis
- •Pigmented lesions
- •Scaly lesions
- •Vesicular lesions
- •Weepy or pustular lesions
- •Figurate erythema
- •Bullous lesions
- •Papular and nodular lesions
- •Photodermatoses
- •Maculopapular lesions
- •Ulcerated lesions
- •Petechial and purpuric lesions
- •Miscellaneous lesions
- •Introduction
- •History and examination findings
- •Investigations
- •Differential diagnosis
- •Platelet abnormality
- •Thrombocytopenia
- •Platelet dysfunction
- •Coagulation abnormality
- •Vitamin K deficiency
- •Factor deficiency
- •Acquired factor inhibitors
- •Vessel wall abnormalities
- •Hereditary
- •Acquired
- •27 Cardiovascular system
- •Coronary heart disease
- •General overview
- •Risk factors
- •Nonmodifiable risk factors
- •Family history
- •Ethnicity
- •Modifiable risk factors
- •Smoking
- •Poor nutrition
- •Hyperlipidaemia
- •Hypertension
- •Diabetes mellitus
- •Obesity
- •Pathophysiology
- •Clinical features
- •Investigations
- •Electrocardiogram
- •Exercise tolerance test
- •Echocardiography
- •CT coronary angiography
- •Nuclear imaging
- •Coronary angiography
- •Treatment
- •Lifestyle changes
- •Drug agents
- •Antiplatelet drugs
- •Nitrates
- •β-Blockers
- •Calcium channel blockers
- •Potassium channel activators
- •Angiotensin-converting enzyme inhibitors
- •Lipid-lowering drugs
- •Revascularization
- •Acute coronary syndrome
- •ST elevation myocardial infarction
- •General overview
- •Clinical features
- •Investigations
- •Management
- •Acute management
- •Non-ST elevation myocardial infarction and unstable angina
- •General overview
- •Clinical features
- •Investigations
- •Risk scoring
- •Management
- •Acute management
- •Subsequent inpatient management of patients with acute coronary syndrome
- •Complications of myocardial infarction
- •Cardiac failure and cardiogenic shock
- •Cardiac rupture
- •Mitral regurgitation
- •Arrhythmias and conduction disturbances
- •Supraventricular arrhythmias
- •Arrhythmias
- •General overview
- •Investigations
- •Sinus tachycardia
- •Atrial fibrillation
- •Aetiology and pathophysiology
- •Complications
- •Management
- •Atrial flutter
- •Paroxysmal supraventricular tachycardia
- •Atrioventricular reentry tachycardia
- •Atrioventricular nodal reentry tachycardia
- •Management
- •Ventricular tachycardia
- •Torsades de pointes
- •Ventricular fibrillation
- •Bradycardias
- •Sinus bradycardia
- •Sick sinus syndrome
- •Heart block
- •Antiarrhythmic drugs
- •Supraventricular arrhythmias only
- •Supraventricular and ventricular arrhythmias
- •Ventricular arrhythmias
- •Heart failure
- •General overview
- •Aetiology
- •Clinical features
- •Left-sided heart failure
- •Right-sided heart failure
- •Congestive cardiac failure
- •Investigations
- •Blood tests
- •Imaging
- •Other
- •Management of acute heart failure
- •Management of chronic heart failure
- •Drug treatment
- •Angiotensin-converting enzyme inhibitors
- •β-Blockers
- •Diuretics
- •Aldosterone antagonists
- •Hydralazine in combination with a nitrate
- •Digoxin
- •Ivabradine
- •Nondrug therapy
- •Implantable cardioverter defibrillator and cardiac resynchronization therapy
- •Left ventricular assist devices
- •Transplantation
- •Hypertension
- •General overview
- •Clinical features
- •Investigations
- •Management
- •Drug treatment
- •Angiotensin-converting enzyme inhibitors
- •Angiotensin II receptor blockers
- •Calcium channel blockers
- •Thiazide diuretics
- •β-Blockers
- •α-Adrenergic receptor blockers
- •Central acting agents
- •Vasodilators
- •Management of hypertension in pregnancy
- •Malignant (accelerated) hypertension
- •Valvular heart disease
- •General overview
- •Mitral stenosis
- •Clinical features
- •Management
- •Mitral regurgitation
- •Clinical features
- •Management
- •Mitral valve prolapse
- •Aortic stenosis
- •Clinical features
- •Management
- •Aortic regurgitation
- •Clinical features
- •Management
- •Tricuspid regurgitation
- •Pulmonary valve lesions
- •Miscellaneous conditions
- •Pericarditis and pericardial effusion
- •Clinical features
- •Management
- •Constrictive pericarditis
- •Cardiomyopathy
- •Hypertrophic obstructive cardiomyopathy
- •Dilated cardiomyopathy
- •Restrictive/infiltrative cardiomyopathy
- •Arrhythmogenic right ventricular dysplasia
- •Infective endocarditis
- •Clinical features
- •Management
- •Rheumatic fever
- •Major Jones criteria
- •Carditis (40%–50%)
- •Polyarthritis (80%)
- •Sydenham chorea (10%)
- •Erythema marginatum (5%)
- •Subcutaneous nodules (rare)
- •Management
- •Atrial myxomata
- •Congenital heart disease in adults
- •Acyanotic conditions
- •Atrial septal defect
- •Ventricular septal defect
- •Patent ductus arteriosus
- •Aortic coarctation
- •Aortic and pulmonary stenosis
- •Cyanotic conditions
- •Tetralogy of Fallot
- •Further reading
- •28 Respiratory system
- •Respiratory failure
- •General overview
- •Type I respiratory failure
- •Causes
- •Management
- •Type II respiratory failure
- •Causes
- •Management
- •Asthma
- •General overview
- •Aetiology
- •Pathophysiology
- •Clinical features
- •Investigations
- •Management
- •Emergency management
- •Long-term management
- •Chronic obstructive pulmonary disease
- •General overview
- •Aetiology
- •Cigarette smoking
- •α1-Antitrypsin deficiency
- •Occupation
- •Pathophysiology
- •Clinical features
- •Investigations
- •Management
- •Short-term management
- •Long-term management
- •Bronchiectasis
- •General overview
- •Clinical features
- •Investigations
- •Management
- •Pneumonia
- •General overview
- •Aetiology
- •Community-acquired pneumonia
- •Atypical pneumonia
- •Hospital-acquired pneumonia (nosocomial)
- •Aspiration pneumonia
- •Opportunistic pneumonia
- •Clinical features
- •Typical
- •Atypical
- •Investigations
- •Bedside
- •Imaging
- •Other tests
- •CURB65 score
- •Management
- •Pulmonary embolism
- •Clinical features
- •Investigations
- •Management
- •Lung cancer
- •General overview
- •Aetiology
- •Pathology
- •Clinical features
- •Paraneoplastic syndrome
- •Investigations
- •Tumour, Node, Metastasis (TNM) staging
- •Management
- •Tuberculosis
- •General overview
- •Pathogenesis
- •Pulmonary tuberculosis
- •Extrapulmonary tuberculosis
- •Clinical features
- •Systemic
- •Pulmonary
- •Extrapulmonary
- •Investigations
- •Management
- •Pneumothorax
- •General overview
- •Clinical features
- •Management
- •Pleural effusion
- •General overview
- •Clinical features
- •Investigations
- •Management
- •Interstitial lung disease
- •General overview
- •Aetiology
- •Known cause:
- •Unknown cause:
- •Clinical features
- •Investigations
- •Management
- •Idiopathic pulmonary fibrosis
- •Sarcoidosis
- •Occupational lung disease
- •Aspergillus and the lung
- •Hypoventilation syndromes and sleep-related respiratory disorders
- •General overview
- •Obstructive sleep apnoea syndrome
- •Obesity hypoventilation syndrome
- •Congenital hypoventilation syndrome
- •Acute respiratory distress syndrome
- •General overview
- •Management
- •Cystic fibrosis
- •General overview
- •Clinical features
- •Management
- •Further Reading
- •Upper gastrointestinal tract
- •Oesophageal disorders
- •Gastro-oesophageal reflux disease
- •Clinical features
- •Investigations
- •Management
- •Complications
- •Hiatus hernia
- •Sliding hiatus hernia
- •Rolling (or paraoesophageal) hiatus hernia
- •Barrett oesophagus
- •Eosinophilic oesophagitis
- •Oesophageal motility disorders
- •Achalasia
- •Oesophageal cancer
- •Clinical features
- •Investigations
- •Management
- •Gastroduodenal disorders
- •Gastroduodenitis and peptic ulcer disease
- •Clinical features
- •Investigations
- •Management
- •Upper gastrointestinal tract haemorrhage
- •Management
- •Gastric cancer
- •Clinical features
- •Management
- •Gastrointestinal stromal tumour
- •Small bowel disorders
- •Malabsorption
- •Coeliac disease
- •Bacterial overgrowth
- •Tropical sprue
- •Whipple disease
- •Neuroendocrine tumours of the bowel
- •Carcinoid tumours
- •Gastrinoma
- •Insulinomas
- •VIPomas
- •Glucagonomas
- •Lower gastrointestinal tract
- •Colorectal disorders
- •Colorectal neoplasia
- •Benign disease
- •Colorectal cancer
- •Screening
- •Diverticular disease
- •Clinical features
- •Investigations
- •Management
- •Clostridium difficile and pseudomembranous colitis
- •Lower gastrointestinal tract bleeding
- •Ischaemic colitis
- •Microscopic colitis
- •Irritable bowel syndrome
- •Clinical features
- •Investigations
- •Management
- •Nonulcer dyspepsia
- •Inflammatory bowel disease
- •General overview
- •Ulcerative colitis
- •Crohn disease
- •Hepatobiliary system
- •Gallbladder disorders
- •Gallstones and biliary colic
- •Clinical features
- •Investigations
- •Management
- •Acute cholecystitis
- •Clinical features
- •Investigations
- •Management
- •Recurrent cholecystitis
- •Biliary tract cancer
- •Cholangiocarcinoma
- •Gallbladder cancer
- •Cancer of the ampulla of Vater
- •Pancreatic disorders
- •Acute pancreatitis
- •Clinical features
- •Investigations
- •Management
- •Chronic pancreatitis
- •Investigations
- •Management
- •Pancreatic cancer
- •Clinical features
- •Investigations
- •Management
- •Liver disorders
- •Chronic liver disease
- •Established chronic liver disease
- •Hepatitis
- •Acute hepatitis
- •Acute viral hepatitis
- •Hepatitis A
- •Epidemiology
- •Hepatitis B
- •Hepatitis C
- •Investigations
- •Management
- •Autoimmune hepatitis
- •Alcoholic liver disease
- •Pathology
- •Clinical features
- •Investigations
- •Prognosis
- •Nonalcoholic steatohepatitis
- •Haemochromatosis
- •Investigations
- •Management
- •Primary biliary cholangitis
- •Primary sclerosing cholangitis
- •Wilson disease (hepatocellular degeneration)
- •Clinical features
- •Investigations
- •Management
- •Hepatic tumours
- •Benign tumours
- •Malignant tumours
- •Miscellaneous conditions
- •α1-Antitrypsin deficiency
- •Liver abscess
- •Budd–Chiari syndrome
- •Further reading
- •Haematuria and proteinuria
- •Proteinuria
- •Benign proteinuria
- •Pathological proteinuria
- •Overflow proteinuria
- •Clinical Features
- •Investigations
- •Urine
- •Blood tests
- •Imaging
- •Histological diagnosis
- •Acute kidney injury
- •Aetiology
- •Clinical features
- •Investigations
- •Urine
- •Blood tests
- •Other tests
- •Management
- •Hyperkalaemia
- •Acidosis
- •Pulmonary oedema
- •Renal replacement therapies
- •Supportive management
- •Summary
- •Chronic kidney disease
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Prevention of decline in renal function
- •Prevention of complications
- •Cardiovascular
- •Renal osteodystrophy
- •Acidosis
- •Anaemia
- •Hyperkalaemia
- •End-stage renal failure
- •Glomerular disease
- •Clinical features
- •Nephritic syndrome
- •Nephrotic syndrome
- •History
- •Investigations
- •Urine
- •Blood tests
- •Imaging
- •Renal biopsy
- •Management
- •Important primary and secondary glomerular diseases
- •Rapidly progressive glomerulonephritis
- •Antiglomerular basement membrane disease
- •IgA nephropathy
- •Lupus nephritis
- •Minimal change nephropathy
- •Focal segmental glomerulosclerosis
- •Membranous glomerulonephritis
- •Membranoproliferative glomerulonephritis
- •Poststreptococcal glomerulonephritis
- •Urinary tract infections
- •Lower urinary tract infections
- •Upper urinary tract infections
- •Clinical features
- •Investigations
- •Management
- •Renal calculi
- •General overview
- •Clinical features
- •Management
- •Urinary tract malignancies
- •Renal cell carcinoma
- •Transitional cell carcinoma
- •Prostatic carcinoma
- •Testicular cancer
- •Miscellaneous conditions
- •Adult polycystic kidney disease
- •Hepatorenal syndrome
- •Thrombotic microangiopathies
- •Sexually transmitted diseases
- •Chlamydia
- •Gonorrhoea
- •Syphilis
- •Further reading
- •Sodium and water balance
- •Hyponatraemia
- •Investigations
- •Hypernatraemia
- •Focal onset seizures
- •Normal awareness
- •Impaired awareness
- •Focal evolving to bilateral convulsive seizures
- •Generalized onset seizures
- •Tonic–clonic (grand mal) seizures
- •Absence attacks (petit mal)
- •Myoclonic seizure
- •Atonic or akinetic epilepsy
- •Aetiology
- •Hypokalaemia
- •Investigations
- •Management
- •Hyperkalaemia
- •Investigations
- •Management
- •Calcium balance
- •Hypocalcaemia
- •Hypercalcaemia
- •Investigations
- •32 Nervous system
- •Cerebrovascular disease
- •Stroke and TIA
- •Intracerebral haemorrhage
- •Subarachnoid haemorrhage
- •Clinical features
- •Investigations
- •Management
- •Subdural haematoma
- •Extradural haematoma
- •Headache
- •Migraine
- •General overview
- •Clinical features
- •Management
- •Cluster headache
- •Tension-type headache
- •Idiopathic intracranial hypertension
- •Trigeminal neuralgia
- •Persistent idiopathic facial pain (atypical facial pain)
- •Dementia
- •Epilepsy
- •General overview
- •Classification
- •Investigations
- •Bedside
- •Imaging
- •Electroencephalogram
- •Management
- •Drug treatment
- •First-line drugs
- •Second-line drugs
- •Withdrawing drugs
- •Other treatment
- •Status epilepticus
- •Pregnancy and epilepsy
- •Driving and work and epilepsy
- •Sudden unexpected death in epilepsy
- •Intracranial tumours
- •General overview
- •Clinical features
- •Raised intracranial pressure
- •Investigations
- •Management
- •Movement disorders
- •Parkinsonism
- •Clinical features
- •Tremor
- •Rigidity
- •Bradykinesia
- •Other features
- •Management
- •Drug therapy
- •Other therapy
- •Tremor
- •Essential tremor
- •Cerebellar tremor
- •Huntington Disease
- •Sydenham chorea
- •Other movement disorders
- •Multiple sclerosis
- •General overview
- •Pathogenesis
- •Clinical features
- •Optic neuritis
- •Diplopia
- •Sensory symptoms
- •Motor weakness
- •Cerebellar signs
- •Other manifestations
- •Investigations
- •Management
- •Central nervous system infection
- •Meningitis
- •General overview
- •Causative organisms
- •Clinical features
- •Meningism
- •Sepsis
- •Raised intracranial pressure
- •Investigations
- •Management
- •Encephalitis
- •Central nervous system abscess
- •Spinal cord infection
- •Spinal cord disorders
- •Spinal cord compression
- •Subacute combined degeneration of the cord
- •Syringomyelia and syringobulbia
- •Peripheral nervous system disorders
- •Peripheral neuropathy
- •Guillain–Barré syndrome
- •Clinical features
- •Investigations
- •Management
- •Entrapment/compression neuropathies
- •Neuromuscular disorders
- •Muscle disorders
- •Myotonic dystrophy (myotonia dystrophica)
- •Muscular dystrophy
- •Duchenne and Becker muscular dystrophy (pseudohypertrophic)
- •Facioscapulohumeral dystrophy (Landouzy–Dejerine syndrome)
- •Limb girdle dystrophy
- •Neuromuscular junction disorders
- •Myasthenia gravis
- •Clinical features
- •Investigations
- •Management
- •Lambert–Eaton myasthenic syndrome
- •Miscellaneous disorders
- •Motor neurone disease
- •Management
- •Horner syndrome
- •Bulbar and pseudobulbar palsy
- •Bell palsy
- •Further reading
- •Diabetes mellitus
- •Aetiology and Pathophysiology
- •Clinical features
- •Macrovascular disease
- •Microvascular disease
- •Diabetic retinopathy
- •Diabetic nephropathy
- •Diabetic neuropathy
- •Diabetic feet
- •Skin
- •Infections
- •Management
- •Diet and lifestyle
- •Oral hypoglycaemic agents
- •Biguanides
- •Sulphonylureas
- •Meglitinides; rapid-acting insulin secretagogues
- •Thiazolidinediones
- •Dipeptidyl peptidase 4 inhibitors
- •Glucagon-like peptide 1 agonists
- •Acarbose
- •Insulin
- •Diabetes and surgery
- •Diabetic emergencies
- •Hypoglycaemia
- •Diabetic ketoacidosis
- •Hyperosmolar hyperglycaemic state
- •Obesity and metabolic syndrome
- •Lipid disorders
- •Aetiology and pathophysiology
- •Primary hyperlipidaemia
- •Secondary hyperlipidaemia
- •Investigations
- •Management
- •Primary prevention
- •Secondary prevention
- •Drugs
- •Thyroid disease
- •Hypothyroidism
- •Management
- •Hyperthyroidism
- •Management
- •Antithyroid drugs
- •Radioiodine
- •Subtotal thyroidectomy
- •Thyroid emergencies
- •Thyrotoxic crisis (‘thyroid storm’)
- •Myxoedema coma
- •Parathyroid disease
- •Hypoparathyroidism
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Hyperparathyroidism
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Pituitary disorders
- •Hypopituitarism
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Pituitary tumours
- •Clinical features
- •Investigations
- •Management
- •Acromegaly
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Surgery
- •Radiotherapy
- •Medical therapies
- •Prognosis
- •Prolactin disorders
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Diabetes insipidus
- •Cranial diabetes insipidus
- •Nephrogenic diabetes insipidus
- •Management
- •Adrenal disorders
- •Cushing syndrome
- •Clinical features
- •Investigations
- •Management
- •Cushing disease
- •Adrenocortical tumours
- •Ectopic adrenocorticotrophic hormone syndrome
- •Addison disease
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Conn syndrome (primary hyperaldosteronism)
- •Clinical features
- •Investigations
- •Management
- •Phaeochromocytoma
- •Clinical features
- •Investigations
- •Management
- •Hypothalamus–pituitary–adrenal axis
- •Dynamic tests for cortisol excess
- •Tests for cortisol deficiency
- •Pituitary function tests
- •Miscellaneous endocrine conditions
- •Multiple endocrine neoplasia
- •Autoimmune polyendocrine syndrome
- •Congenital adrenal hyperplasia
- •Metabolic bone disease
- •Osteoporosis
- •Aetiology
- •Primary osteoporosis
- •Secondary osteoporosis
- •Clinical features
- •Investigations
- •Management
- •General principles
- •Drugs
- •Paget disease
- •Clinical features
- •Investigations
- •Management
- •Bisphosphonates
- •Calcitonin
- •Surgery
- •Osteomalacia
- •Aetiology
- •Clinical features
- •Investigations
- •Biochemistry
- •Imaging
- •Management
- •Renal osteodystrophy
- •Management
- •Further reading
- •34 Musculoskeletal system
- •Osteoarthritis
- •Pathology
- •Clinical features
- •Management
- •Rheumatoid arthritis
- •Pathology
- •Clinical features
- •Management
- •Spondyloarthropathies
- •Ankylosing spondylitis
- •Pathology
- •Clinical features
- •Management
- •Reactive arthritis
- •Pathology
- •Clinical features
- •Management
- •Psoriatic arthritis
- •Enteropathic arthropathies
- •Crystal arthropathy
- •Gout
- •Pathology
- •Clinical features
- •Management
- •Pseudogout
- •Connective tissue disorders
- •Systemic lupus erythematosus
- •Pathology
- •Clinical features
- •Treatment
- •Systemic sclerosis
- •Pathology
- •Clinical features
- •Management
- •Polymyositis and dermatomyositis
- •Pathology
- •Clinical features
- •Management
- •Sjögren syndrome
- •Vasculitis
- •General overview
- •Eosinophilic granulomatosis with polyangiitis
- •Granulomatosis with polyangiitis
- •Henoch–Schönlein purpura
- •Kawasaki disease
- •Microscopic polyangiitis
- •Polyarteritis nodosa
- •Behçet disease
- •Polymyalgia rheumatica and giant cell arteritis
- •Polymyalgia rheumatica
- •Giant cell arteritis
- •Antiphospholipid syndrome
- •35 Skin disease
- •Skin manifestations of systemic disease
- •Diabetes mellitus
- •Inflammatory bowel disease
- •Coeliac disease
- •Hyperthyroidism
- •Malignant disease
- •Sarcoidosis
- •Rheumatic fever
- •Neurofibromatosis
- •Lyme disease (borreliosis)
- •Hyperlipidaemia
- •Skin disease
- •Psoriasis
- •Clinical features
- •Management
- •Eczema/dermatitis
- •Clinical features
- •Management
- •Acne vulgaris
- •Actinic keratosis
- •Seborrhoeic keratosis
- •Herpes simplex
- •Herpes (varicella) zoster
- •Lichen planus
- •Erythema multiforme
- •Stevens–Johnson syndrome and toxic epidermal necrolysis
- •Pemphigus vulgaris and bullous pemphigoid
- •Erythema nodosum
- •Vitiligo
- •Pyoderma gangrenosum
- •Neoplastic disease
- •Basal cell carcinoma
- •Squamous cell carcinoma
- •Malignant melanoma
- •Infections
- •Impetigo
- •Cellulitis
- •Necrotizing fasciitis
- •36 Haematological disorders
- •Anaemia
- •Diagnosis
- •Management
- •Iron replacement
- •Vitamin B12 and folate replacement
- •Blood transfusion
- •Splenectomy
- •Erythropoietin
- •Causes of anaemia
- •Anaemia of chronic disease
- •Clinical features
- •Management
- •Haemolytic anaemia
- •Clinical features
- •Management
- •Sickle cell anaemia
- •Clinical features
- •Management
- •Thalassaemia
- •Clinical features
- •Management
- •Aplastic anaemia
- •Clinical features
- •Management
- •Leukaemia
- •Acute lymphoblastic leukaemia
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Acute myeloid leukaemia
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Chronic lymphocytic leukaemia
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Chronic myeloid leukaemia
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Multiple myeloma
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Lymphoma
- •Hodgkin disease
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Non-Hodgkin lymphoma
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Myelodysplastic syndromes
- •Classification
- •Clinical features
- •Management
- •Myeloproliferative disease
- •Polycythaemia vera
- •Essential thrombocythaemia
- •Primary myelofibrosis
- •Bleeding disorders
- •Haemophilia A
- •Haemophilia B (Christmas disease)
- •Von Willebrand disease
- •Immune thrombocytopenia
- •Disseminated intravascular coagulation
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Thrombotic disorders and thromboembolism
- •Aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Thrombotic thrombocytopenic purpura
- •Haemolytic uraemic syndrome
- •37 Infectious diseases
- •General overview
- •HIV and AIDS
- •Epidemiology and aetiology
- •Pathology
- •Clinical features
- •Primary HIV infection
- •Clinical stage 1
- •Clinical stage 2
- •Clinical stages 3 and 4
- •Treatment and prognosis
- •Prevention
- •Malaria
- •Epidemiology and aetiology
- •Pathology
- •Clinical features
- •Treatment and prognosis
- •Prevention
- •Diarrhoeal disease
- •Drug-resistant bacteria
- •Other resistant bacteria
- •38 Drug overdose and abuse
- •General overview
- •Common presentation, investigations and management
- •History
- •Examination
- •How ill is the patient?
- •Is there any evidence to suggest an underlying cause?
- •Have any complications occurred?
- •Investigations
- •Management
- •Supportive care
- •Preventing absorption
- •Increase elimination of drug
- •Specific antidotes
- •Psychiatric and social assessment
- •Paracetamol overdose
- •Illegal drugs
- •Alcohol misuse and withdrawal
- •Alcohol withdrawal
- •Wernicke encephalopathy/Korsakoff psychosis
- •Long-term treatment
- •Further reading
- •Self-Assessment
- •SBA answers
- •EMQ answers
- •Index

Stroke and TIA
Chapter Summary
• Stroke is described as a focal or global dysfunction of cerebral function lasting longer
than 24 hours.
• If symptoms are present for less than 24 hours, the condition is termed ‘transient
ischaemic attack’ (‘TIA’).
• The history and examination will point towards the underlying cause and the territory of
the brain affected.
• Thrombolysis is considered as treatment for ischaemic stroke provided the patient
presents within 4.5 hours of the onset of symptoms.
• Antiplatelet therapy is usually used in patients following a stroke for secondary
prevention.
128

Lumps
21
INTRODUCTION
Lumps and bumps are extremely common presenting
patient complaints. A lump can also be identified by the
clinician on examination. Aetiologically, lumps generally
fall into one of the following categories:
• congenital or acquired
• inflammatory (either acute or chronic)
• traumatic
• neoplastic (primary or secondary and malignant or
benign)
• other (e.g. metabolic, degenerative, hormonal)
A detailed history, examination and subsequent investigations will help in determining the differential diagnosis, and
therefore management for a mass found. Management can
range from simple explanation, reassurance and monitoring
to urgent referral for surgery.
HISTORY AND EXAMINATION FINDINGS
A methodological approach to history taking and examination with particular emphasis on mass inspection is crucial
in determining the potential cause.
It is important to determine where was the lump found.
Common places include the neck, breast, axilla, scrotum
and perianal area, and skin. To a clinician the site will give
important clues regarding the anatomical origin of the lump
and potential underlying disease.
Important questions to ask about the lump include:
• When was the lump first noticed?
• Has it developed with time?
• Is it tender?
• Are there any other lumps or associated symptoms?
It is important to inquire about the patient’s medical
history as previous illness could itself be a cause of lump
development. Ask if there is a history of any other lumps
or a history of trauma and whether there is a history of
foreign travel.
The examination should focus on describing the lump.
It is important to try to establish an anatomical plane of the
swelling as it may be arising from the skin, subcutaneous
tissue, tendon, muscle, bone or internal organ.
Inspection and palpation of the swelling will help further characterize the swelling. These can be remembered
by the S’s:
• Site: should be described anatomically (e.g. lump in
the breast). If it is difficult to ascribe other features,
neighbouring structures should be identified.
• Size: needs to be measured with a diagram recording
the position, dimension and shape.
• Shape: certain lumps can have a characteristic shape
(e.g. two-lobed thyroid).
• Surface: comment on regularity, whether its uniform
or smooth or irregular. Margins of the swelling should
also be characterized as well- or ill-defined, smooth
and regular or irregular.
• Surroundings: examine around the lump, its regional
lymph nodes or, if it is a lymph node, its draining area.
• Structure (consistency): the lump may be solid or
gaseous, soft, fluctuant or firm. Fluid lumps can be
transilluminated, and they are compressible with
displacement of the fluid in two planes.
• Stability: describe if the lump is mobile or fixed to
surrounding/underlying structures.
• Sound: auscultate the swelling looking for bruits or
bowel sounds in a hernia.
• Secretion: look for evidence of discharge or a punctum.
• Sensation: feel the lump for temperature (may be
raised over inflamed lumps), tenderness and pulsation
(distinguish between expansile and transmitted
pulsation).
• Sign of emptying or indentation: examine if the lump
decreases in size or disappears when compressed or
remains indented.
It is extremely important to keep a good record of the examined lump to ensure an appropriate timeline, and monitor
any changes or developments. A diagram should be drawn
of the findings or a picture can be kept in the records with
appropriate patient consent.
HINTS AND TIPS
Remember to always examine the corresponding
area of the patient on the opposite side of the
body.
CLINICAL NOTE
A sebaceous cyst can be differentiated from lipoma
by the presence of a punctum on its surface.
129

Lumps
INVESTIGATIONS
Often diagnosis of a lump can be made clinically and does
not require investigating. When, however, this is not adequate, several tests can be helpful:
• Ultrasound scan or Doppler studies are useful for
fluid-filled lumps or to determine heterogeneity of a
swelling.
• Excision biopsy for histology.
• Aspiration or fluid for microscopy and culture, and
cytology.
• Fine-needle aspiration is used in solid masses for
cytology.
• Blood tests, including inflammatory markers, are useful
if the lump is thought to be inflammatory.
• CT and MRI scans are extremely useful in
determining the characteristics of a lump,
determining surrounding anatomy or investigating
the presence of other masses.
DIFFERENTIAL DIAGNOSIS
The features of the lump, its anatomical position and its origin will determine the most likely diagnosis of the lump.
Table21.1 describes the most common differential diagno-
ses based on anatomical location.
Localized lymphadenopathy
‘Localized lymphadenopathy’ describes a lymph nodes that
is abnormal in size, consistency or number. As a general
rule, in adults abnormal size is defined as a short axis of the
node of longer than 10 mm. There is a regional variation between lymph nodes, however, and a specific enlarged lymph
node should be investigated based on individual criteria.
Localized lymphadenopathy is most commonly caused
by a local site of infection (e.g. an abscess on the upper limb
will cause localized lymphadenopathy in the same area).
Generalized lymphadenopathy
This is when more than two noncontiguous lymph node
groups are found to be enlarged. Lymph nodes can increase in size depending on age, location and their current
immune activity. Most generalized lymphadenopathy is
caused by benign conditions such as bacterial or viral infections. Lymphoma, malignancy (e.g. acute leukaemia), HIV
infection, tuberculosis (Fig.21.1) or autoimmune disorders
(e.g. systemic lupus erythematosus) can also be the cause.
The history and examination are important in determining the cause. Constitutional symptoms of fever,
night sweats and malaise should always raise suspicion.
Superclavicular and infraclavicular lymph nodes are always
Table21.1 Anatomical distribution of lumps and their
most likely causes
Location Differential diagnosis
Neck lump 1 Anterior triangle:
Breast lumps Simple cysts
Axilla Breast cancer
Groin and
scrotum
Abdomen Enlarged abdominal organs (e.g. liver
Other Epitrochlear lymph nodes: characteristic
• pharyngeal pouch
• thyroid disease
• branchial cyst
• parotid gland swelling
• lymphadenopathy
2 Posterior triangle:
• carotid body tumour
• carotid artery aneurysm
• cystic hygroma
• cervical rib
• lymphadenopathy
3 Midline swelling:
• thyroglossal cyst
• lymphadenopathy
Breast abscess
Fibroadenomata (mobile lump)
Fibroadenosis (lumpy breast)
Fat necrosis
Breast cancer
Metastatic disease
Hidradenitis suppurativa
Sebaceous cyst
Lipoma
Hernias (inguinal or femoral)
Epididymal cyst
Epididymo-orchitis
Hydrocele
Haematocele
Sebaceous cyst
Psoas muscle abscess
Femoral artery aneurysm
Saphena varix
Cancer
or spleen)
Fibroids
Abdominal cancer
Abdominal aortic aneurysm
Pregnancy
of Hodgkin disease
Supraclavicular lymph node (Virchow
node): strongly suggestive of abdominal
malignancy (most likely gastric)
suggestive of malignancy. Firm, nontender nodes increase
the risk of malignancy.
Investigations should be directed by the history and ex-
amination, and can include:
• simple blood tests (e.g. full blood count, blood film and
inflammatory markers)
• infection swabs for primary disease site
130

Fig.21.1 Cutaneous tuberculosis. Lumps can be
superficial but can also infiltrate deeper tissues. Reprinted
with permission from Bolognia etal. Dermatology 3rd
edition. (Figure taken from Figure75.15. Scrofuloderma
Dermatology: 2-Volume Set, 3rd Edition Expert Consult
Premium Edition - Enhanced Online Features and Print by
Jean L. Bolognia, Joseph L. Jorizzo and Julie V. Schaffer)
• viral titres (e.g. hepatitis)
• imaging (chest radiograph, ultrasound scans, CT/MRI
scan)
Management is directed by the diagnosis. The most important aspect concentrates on eliminating a serious underlying cause. Patients are advised to monitor the condition
and seek help if symptoms persist or lymph nodes enlarge
or multiply. As a general rule, the presence of any of the
Differential diagnosis
following should raise suspicion for further investigations
or referral:
• presence for more than 6weeks
• lymph nodes greater than 2 cm or increasing in size
• widespread nature
• associated constitutional symptoms or splenomegaly
Treatment is of the underlying condition and determines
the prognosis.
2121
Splenomegaly
The spleen plays an important role in immunity, and acts
as a large lymph node. It has usually reached twice its original size by the time it is palpable. Splenomegaly most commonly presents as left upper quadrant mass, abdominal
pain or early satiety if the spleen compresses the stomach.
The presence of splenomegaly should raise suspicion of
a potentially serious underlying condition and should be investigated. Specific tests to consider include bone marrow,
liver and lymph node biopsy.
The causes of splenomegaly include:
• haematological causes: leukaemia, lymphoma,
haemolytic anaemia, myelofibrosis, polycythaemia
vera;
• infections: tuberculosis, malaria, schistosomiasis, viral
hepatitis, infective endocarditis, leishmaniasis;
• tumours and cysts: abscess, splenic metastases,
haemangioma;
• connective tissue disorder: systemic lupus
erythematous, Felty syndrome;
• congestive splenomegaly: heart failure, cirrhosis, portal
and splenic vein obstruction, Budd–Chiari syndrome.
If massive splenomegaly is present, chronic myeloid leukaemia, myelofibrosis, leishmaniasis and malaria should be
suspected.
Management is with treatment of the underlying condition. Splenectomy can be considered.
Chapter Summary
• Lumps are one of the most common presenting complaints of patients. They can be signs
of local infection or manifest themselves as features of a serious underlying condition.
The most important aspects in determining the origin of a lump and establishing the
differential diagnosis is thorough history taking and clinical examination.
131

This page intentionally left blank

Focal neurological deficits
22
INTRODUCTION
Focal neurological deficits or signs describe an impairment of
the nervous system that affects a specific part of the body. These
can include muscle weakness or abnormal sensation, and can
Table22.1 Differential diagnosis of sensory and/or motor neurological deficits
Site of lesion Examples
Muscle (see
Chapters32–34)
Neuromuscular junction
(see Chapter32)
Peripheral nerves (see
Chapters32–36)
Congenital
Dystrophy: Duchenne, Becker, limb girdle, facioscapulohumeral
Myotonia: myotonic dystrophy, myotonia congenita (Thomsen disease)
Acquired
Drugs: steroids, cholesterol-lowering drugs (statins and fibrates), penicillamine
Endocrine: Cushing syndrome, thyrotoxicosis, hypothyroidism and hyperparathyroidism
Infection: viral (influenza, HIV infection), parasitic (toxoplasmosis, trichinosis) and bacterial
(Borrelia infection, Clostridium perfringens infection)
Inflammation and autoimmune: polymyositis, dermatomyositis and sarcoidosis
Metabolic: periodic paralyses, glycogen storage diseases and mitochondrial myopathy
Toxin: alcohol
Tumour: sarcoma and paraneoplastic syndromes
Myasthenia gravis
Lambert–Eaton myasthenic syndrome
Clostridium botulinum infection (botulism)
Mononeuropathy (only one nerve involved)
Entrapment: carpal tunnel syndrome (median nerve), and meralgia paraesthetica (lateral
cutaneous nerve of thigh)
Stretching: ulnar nerve neuropathy with increased carrying angle
Trauma
Compression: e.g. by tumour, as in neurofibromatosis, or AVM
Infarction: e.g. due to vasculitis
Mononeuritis multiplex/multifocal neuropathy (two or more nerves involved)
Connective tissue disease: PAN, SLE, RA
Infection: leprosy, herpes zoster, HIV infection, Lyme disease
Inflammation: sarcoidosis
Metabolic: DM
Infiltration: amyloidosis
Tumour: infiltration, paraneoplastic syndrome, neurofibromatosis
Polyneuropathy (with symmetrical deficit most marked distally)
result from disease occurring anywhere along the pathway of a
specific nerve or nerves. Many pathological processes can lead
to this presentation. The differential diagnosis is approached
logically according to the likely anatomical site (the level of the
lesion) and the possible causes at that location (Table22.1).
(Continued)
133

Focal neurological deficits
Table22.1 Differential diagnosis of sensory and/or motor neurological deficits—cont’d
Site of lesion Examples
Congenital
Charcot–Marie–Tooth disease (hereditary sensorimotor neuropathy)
Refsum disease
Friedreich ataxia (spinal cord pathology usually coexists)
Acquired
Connective tissue disease: PAN, SLE, RA
Drugs: nitrofurantoin, metronidazole, vinca alkaloids, platinum-containing drugs, isoniazid
Inflammation: AIDP (Guillain–Barré syndrome), CIDP, multifocal motor neuropathy
Metabolic: DM, renal failure (uraemic neuropathy), porphyria
Toxins: alcohol, lead, mercury and arsenic
Tumour: paraneoplastic syndrome and paraproteinaemias
Infiltration: amyloidosis
Vitamin deficiency: thiamine (B1), niacin (B6), B12, folate
Brachial or lumbar plexus Compression: cervical rib, thoracic outlet syndrome
Idiopathic: neuralgic amyotrophy
Metabolic: DM
Trauma: birth injury (Erb and Klumpke palsies) and, classically, motorbike accidents
Tumour: malignant infiltration (e.g. Pancoast tumour)
Spinal nerve root Infection (e.g. pyogenic meningitis, syphilis, CMV infection)
Prolapsed intervertebral disc and spondylosis
Spinal stenosis
Tumour
Vertebral fracture dislocation
Anterior horn cell (see
Chapter32)
Spinal cord
(see Chapter32)
Cerebellum
(see Chapter32)
Motor neurone disease
Spinal muscular atrophy
Poliomyelitis
Degeneration: osteoarthritis (osteophytes may cause spinal stenosis or foraminal stenosis)
Infection: abscess, HIV infection, TB (Pott disease)
Inflammation: MS, sarcoidosis, RA (atlantoaxial subluxation)
Metabolic: Paget disease causing spinal stenosis or compression
Trauma: direct; prolapsed intervertebral disc; radiotherapy
Tumour: metastases, neurofibroma, meningioma, glioma, ependymoma
Vascular: anterior spinal artery occlusion, aortic dissection, aortic aneurysm (emboli), AVM,
vasculitis
Vitamin deficiency: subacute combined degeneration of the spinal cord (vitamin B12)
Other: syringomyelia, spina bifida, motor neurone disease
Congenital
Friedreich ataxia and spinocerebellar ataxias
Ataxia telangiectasia
Acquired
Endocrine: hypothyroidism
134

History and examination findings
Table22.1 Differential diagnosis of sensory and/or motor neurological deficits—cont’d
Site of lesion Examples
Infection: abscess, meningoencephalitis, postinfectious encephalitis
Inflammation: MS
Toxins: alcohol, lead, anticonvulsants
Trauma: ‘punch-drunk’ syndrome
Tumour: metastases, acoustic neuroma, haemangioblastoma (von Hippel–Lindau disease),
Vascular: infarction, haematoma, AVM
Cerebral hemispheres (see
Chapter32)
Hydrocephalus: primary or secondary
Infection: abscess, meningitis, encephalitis; HIV infection (e.g. AIDS dementia complex),
Inflammation: sarcoidosis, SLE, MS
Metabolic: phenylketonuria, Wilson disease (basal ganglia), other inborn errors of
Toxic: alcohol
Trauma: haematoma, diffuse axonal injury
Tumour: primary or secondary
Vascular: infarction, haemorrhage, AVM, aneurysm
Vitamin deficiency: thiamine (B1), niacin (B6), B
AIDP, Acute inflammatory demyelination polyneuropathy; AVM, arteriovenous malformation; CIDP, chronic inflammatory demyelinating
polyneuropathy; CMV, cytomegalovirus; DM, diabetes mellitus; MS, multiple sclerosis; PAN, polyarteritis nodosa; RA, rheumatoid arthritis;
SLE, systemic lupus erythematosus; TB, tuberculosis.
paraneoplastic degeneration
Degenerative disease
malaria, rabies, TB, syphilis
metabolism
12
2222
HISTORY AND EXAMINATION
FINDINGS
History
Despite the vast number of potential underlying diseases,
a lesion at a particular point in the pathway between the
brain and muscle or skin will always produce the same clinical signs regardless of the cause. There are five important
aspects to consider in the history.
Pattern of deficit
Table 22.2 summarizes characteristic symptoms and signs
that arise because of a lesion at a specific neurological level. If
the neurological abnormalities do not fit with a single localized lesion, consider multiple sclerosis (MS), motor neurone
disease, paraneoplastic neuropathy, multisystem disorders
(e.g. sarcoidosis or vasculitis) or, rarely, a functional disorder.
Onset
Sudden onset usually indicates a vascular problem such as infarction or haemorrhage. Lesions due to trauma (e.g. enlarging
haematoma), MS, infection (e.g. abscess), acute prolapsed disc
and myelitis can also develop rapidly (e.g. over hours). An insidious onset, over weeks to months, is more typical of cervical
spondylosis, motor neurone disease, neoplasm or myopathy.
Precipitants
Trauma may result in muscular and neurological deficits.
Acute myasthenia can be precipitated by intercurrent illness
(particularly infection) or drugs (aminoglycosides or penicillamine). The incidence of MS relapses may increase in
the postpartum period and during systemic infections, and
symptoms may be exacerbated by exertion, hot weather or a
hot bath (Uhthoff phenomenon).
Progression
Many lesions cause gradually progressive, unremitting
disease, including tumours, motor neurone disease, hereditary ataxias, syringomyelia and degenerative brain
diseases. Intermittent deficits can be due to transient ischaemic attacks, epilepsy, migraine and myasthenia gravis.
MS is characterized by the development of lesions which
are dissociated in time and site. Symptoms and signs due
135

Focal neurological deficits
Table22.2 Symptoms and signs associated with different anatomical lesions
Site of anatomical
lesion Symptoms Specific signs Muscle Reflexes Sensation
Brachial or lumbar
plexus
Anterior spinal root Muscle weakness Wasting
Posterior spinal root Pain in skin and
Anterior horn cell Muscle weakness Wasting
Spinal cord Pain at site of lesion
Cerebellum Unsteadiness
Cerebral hemispheres Determined by
Muscle weakness
Sensory
disturbance
muscle supplied by
that root
worse on coughing,
sneezing, at night
Urinary/bowel
disturbance
Leg weakness
Sensory
disturbance
Tremor
Altered speech
Falls
Poor coordination
site of lesion
Weakness
Seizures
Altered speech
Disturbed higher
functions
Wasting
Normal Reduced or
At level of
Broad-based gait
Falling to side of
lesion
Intention tremor
Past-pointing
dysdiadochokinesis
Nystagmus
Staccato speech
Postural drift
Dysphasia
Dysarthria
Visual disturbance
Fasciculation
Reduced tone
Reduced power
in distribution of
affected nerves
Fasciculation
Reduced tone
Reduced power
in distribution of
affected root
Fasciculation
Reduced tone
Reduced power
in distribution of
affected nerve
lesion: wasting,
fasciculation,
reduced tone,
reduced power
Below lesion:
spasticity,
increased tone,
reduced power
Reduced tone
Normal power
Increased tone
‘Clasp-knife’
rigidity
Wasting only if
disuse
Reduced power
in pyramidal
distribution (flexors
stronger than
extensors in arms,
extensors stronger
than flexors in legs)
Reduced or
absent
Reduced or
absent
absent
Reduced or
absent
At level of lesion:
reduced or
absent
Below lesion:
increased,
Upgoing plantar
response
Pendular Normal
Brisk
Upgoing plantar
response
Deficit in
distribution of
affected nerves
Normal
Deficit in
distribution of
affected root
Normal
Below lesion:
ipsilateral
posterior
column loss
(proprioception,
vibration sense)
contralateral
spinothalamic
loss (pain and
temperature)
Deficit
determined by
site of lesion
136

History and examination findings
Table22.2 Symptoms and signs associated with different anatomical lesions—cont’d
Site of anatomical
lesion Symptoms Specific signs Muscle Reflexes Sensation
Muscle Weakness
Neuromuscular
junction
Peripheral nerve Muscle weakness
LEMS, Lambert–Eaton myasthenic syndrome.
(particularly
climbing stairs,
getting out of chair)
Pain (inflammation)
Diplopia
Dysphagia
Altered voice
Proximal muscle
weakness
Sensory
disturbance
May be purely
sensory, purely
motor or mixed
Myotonia
in myotonia
dystrophica
Calf
pseudohypertrophy
and Gowers sign in
Duchenne muscular
dystrophy
Fatigable
weakness with
repetition in
myasthenia gravis
Increasing strength
with repetition in
LEMS
Mononeuropathy
and mononeuritis
multiplex – signs
in distribution of
affected nerves
Polyneuropathy –
signs symmetrical
and distal (glove
and stocking)
Wasting (usually
proximal)
Tone normal or
reduced
Power reduced
Wasting only if
severe
Tone normal
Power alters with
repetition
Wasting
Fasciculation
Reduced tone
Reduced power
Usually normal;
reduced or absent
in severe muscle
disease only
Downgoing plantar
response
Normal Normal
Reduced or absent Deficit of all
Normal
modalities (glove
and stocking
distribution)
2222
to trauma or vascular events may slowly abate with time or
remain static following the initial event.
Evidence of cause
The following factors provide evidence of a cause:
• family history: e.g. hereditary ataxias, phenylketonuria,
neurofibromatosis;
• drug history: e.g. phenytoin (cerebellar signs), vinca
alkaloids and platinum-containing drugs (peripheral
neuropathy), penicillamine (myasthenia gravis);
• dietary history: intake of vitamins B1, B6 and B12 and
folate;
• alcohol history;
• preexisting illness: e.g. diabetes, hypertension
(cerebrovascular disease), rheumatoid arthritis,
tuberculosis or malignancy;
• history of trauma;
• associated features: e.g. swinging pyrexia and rigors
(abscess), vasculitic symptoms (connective tissue
disease), anorexia and weight loss (malignancy),
symptoms of hypothyroidism or hyperthyroidism;
• travel history (exposure to infections, e.g. Lyme
disease) and risk factors for HIV infection.
Examination
Perform a full neurological examination (see Chapter2).
The clinical examination should aim to answer three
questions. Firstly, where is the anatomical site of the lesion
or lesions? Secondly, is there anything to suggest the underlying pathological process? Finally, what disability does the
patient have because of the neurological deficit?
The anatomical site of the lesion
From the moment you meet the patient, observe the patient
carefully. How does the patient shake your hand? Can the
patient lift their arm up? Can they let go of your hand (myotonia)? Watch how the patient undresses or gets on to the
bed. A severe deficit will often become apparent before you
start the examination.
Table22.2 should help you identify where the anatomical
lesion is likely to be, based on the neurological signs present.
The underlying cause
Once the site of the lesion has been identified, think of the
differential diagnosis as outlined at the beginning of this
chapter.
137
Соседние файлы в папке Библиотека им академика М.И. Перельмана
